Core Scientific- Warrants Tranche 2 (23/01/2029) Receivables

Core Scientific- Warrants Tranche 2 (23/01/2029) posts a receivables of $280M as of September 2026. In the prior-year period, the figure was $0. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Core Scientific- Warrants Tranche 2 (23/01/2029)'s receivables was $0. The latest reading is $280M (period ending September 2026). Use the history and growth charts on this page for a longer lookback.

Receivables is one piece of Core Scientific- Warrants Tranche 2 (23/01/2029)'s financial statement story. At $280M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for CORZZ's receivables usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Core Scientific- Warrants Tranche 2 (23/01/2029)'s other metric pages and overview cover the third.

Judging Core Scientific- Warrants Tranche 2 (23/01/2029) against Technology peers is usually better than using a market-wide rule of thumb. Business models inside Technology are more comparable, which makes gaps in receivables easier to interpret. Start with $280M here, then scan peer and history charts to see if the gap is persistent.